Published in Clin Rheumatol on February 03, 2015
Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum (2006) 10.39
Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care (1995) 10.36
Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol (1986) 5.82
Severe psoriasis--oral therapy with a new retinoid. Dermatologica (1978) 5.67
Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis (2005) 4.67
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum (2003) 1.92
Treatment recommendations for psoriatic arthritis. Ann Rheum Dis (2008) 1.85
The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum (2009) 1.84
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis (2010) 1.63
Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol (2003) 1.48
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis (2011) 1.41
Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. Arthritis Rheum (2002) 1.26
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis (2012) 1.15
The cost of rheumatoid arthritis. Br J Rheumatol (1996) 1.14
The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol (2007) 1.01
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford) (2008) 0.91
Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J Rheumatol (2014) 0.86
The impact of anti-TNF-alpha therapy on the nature of service provision. Rheumatology (Oxford) (2005) 0.80
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse. Int J Immunopathol Pharmacol (2013) 0.80
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet (2010) 5.04
Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ (2003) 4.18
Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. BMJ (2011) 3.60
Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial. BMJ (2010) 3.56
Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ (2010) 3.19
Michelangelo and medicine. J R Soc Med (2002) 3.10
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet (2008) 2.88
Alexander Technique Lessons or Acupuncture Sessions for Persons With Chronic Neck Pain: A Randomized Trial. Ann Intern Med (2015) 2.81
Does risk to humans justify high cost of fighting bovine TB? Nature (2008) 2.49
Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ (2005) 2.00
Methodological bias in cluster randomised trials. BMC Med Res Methodol (2005) 1.91
Acupuncture and counselling for depression in primary care: a randomised controlled trial. PLoS Med (2013) 1.90
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis (2002) 1.89
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
Pressure relieving support surfaces (PRESSURE) trial: cost effectiveness analysis. BMJ (2006) 1.75
Report on the Second international Enthesitis Workshop. Arthritis Rheum (2003) 1.73
Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J Rheumatol (2005) 1.72
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol (2011) 1.71
Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol (2007) 1.69
A systematic meta-analytic review of evidence for the effectiveness of the 'Fast ForWord' language intervention program. J Child Psychol Psychiatry (2010) 1.66
Differential recruitment in a cluster randomized trial in primary care: the experience of the UK back pain, exercise, active management and manipulation (UK BEAM) feasibility study. Clin Trials (2005) 1.64
Consensus on a core set of domains for psoriatic arthritis. J Rheumatol (2007) 1.60
Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial. Trials (2014) 1.56
Educating nursing home staff on fracture prevention: a cluster randomised trial. Age Ageing (2007) 1.54
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Cluster randomized controlled trials. J Eval Clin Pract (2005) 1.51
The composite DAS Score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making. J Clin Rheumatol (2009) 1.50
Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum (2008) 1.48
Measuring disability in ankylosing spondylitis: comparison of bath ankylosing spondylitis functional index with revised Leeds Disability Questionnaire. J Rheumatol (2002) 1.46
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood (2008) 1.45
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. Leuk Lymphoma (2012) 1.44
Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 1.43
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis (2011) 1.41
Did the "Pigeon Chested Man" have Marfan's syndrome? J R Soc Med (2002) 1.37
The impact of rheumatoid arthritis on foot function in the early stages of disease: a clinical case series. BMC Musculoskelet Disord (2006) 1.31
Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res (Hoboken) (2010) 1.31
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis (2012) 1.30
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum (2003) 1.27
The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum (2002) 1.23
The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord (2013) 1.22
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis (2011) 1.17
A randomized controlled trial of foot orthoses in rheumatoid arthritis. J Rheumatol (2002) 1.16
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis (2012) 1.15
Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterol (2012) 1.15
Protocol for the ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial: a pragmatic multi-centre randomised controlled trial of surgical versus non-surgical treatment for proximal fracture of the humerus in adults. BMC Musculoskelet Disord (2009) 1.13
The DAMASK trial protocol: a pragmatic randomised trial to evaluate whether GPs should have direct access to MRI for patients with suspected internal derangement of the knee. BMC Health Serv Res (2006) 1.11
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer (2010) 1.09
Acupuncture, Counseling, and Usual care for Depression (ACUDep): study protocol for a randomized controlled trial. Trials (2012) 1.07
Use of the h-index to measure the quality of the output of health services researchers. J Health Serv Res Policy (2014) 1.06
GALA: an international multicentre randomised trial comparing general anaesthesia versus local anaesthesia for carotid surgery. Trials (2008) 1.06
Outcome measures in psoriatic arthritis. J Rheumatol (2007) 1.05
Pes planovalgus in RA: a descriptive and analytical study of foot function determined by gait analysis. Musculoskeletal Care (2003) 1.04
Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann Rheum Dis (2010) 1.03
Operational definitions and observer reliability of the plain radiographic features of psoriatic arthritis. J Rheumatol (2003) 1.01
The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands. J Rheumatol (2009) 1.00
Exploring the relationship between fear of falling and neuroticism: a cross-sectional study in community-dwelling women over 70. Age Ageing (2005) 1.00
A randomised controlled trial of yoga for the treatment of chronic low back pain: results of a pilot study. Complement Ther Clin Pract (2010) 1.00
Improving response rates using a monetary incentive for patient completion of questionnaires: an observational study. BMC Med Res Methodol (2007) 0.99
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis (2011) 0.98
Use of weekly, low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial. BMJ (2011) 0.97
Use of conservative and surgical foot care in an inception cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) (2011) 0.97
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis (2011) 0.96
Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care. BMC Gastroenterol (2012) 0.96
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res (2008) 0.96
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology (Oxford) (2013) 0.95
Cluster randomized trials produced similar results to individually randomized trials in a meta-analysis of enhanced care for depression. J Clin Epidemiol (2007) 0.94
Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis (2010) 0.94
Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial. BMC Gastroenterol (2010) 0.93
International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res (2013) 0.93
The effectiveness and cost-effectiveness of the Family Nurse Partnership home visiting programme for first time teenage mothers in England: a protocol for the Building Blocks randomised controlled trial. BMC Pediatr (2013) 0.93
Development of diagnostic criteria for psoriatic arthritis: methods and process. Curr Rheumatol Rep (2004) 0.93
A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum (2004) 0.93
Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum (2012) 0.92
Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. Br J Haematol (2008) 0.92
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. Br J Haematol (2011) 0.92
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann Rheum Dis (2012) 0.91
Systematic techniques for assisting recruitment to trials (START): study protocol for embedded, randomized controlled trials. Trials (2014) 0.91
A pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocol. Complement Ther Clin Pract (2009) 0.91
The concept of disease modification in spondyloarthropathy. J Rheumatol (2002) 0.90
Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology (2012) 0.89
Bias in recruitment to cluster randomized trials: a review of recent publications. J Eval Clin Pract (2011) 0.89
A randomized trial of electronic reminders showed a reduction in the time to respond to postal questionnaires. J Clin Epidemiol (2010) 0.89
Potential use of optical coherence tomography and high-frequency ultrasound for the assessment of nail disease in psoriasis and psoriatic arthritis. Dermatology (2013) 0.88
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group. Ann Hematol (2012) 0.88
Changes in 3D joint kinematics support the continuous use of orthoses in the management of painful rearfoot deformity in rheumatoid arthritis. J Rheumatol (2003) 0.88
Outcome measures in psoriatic arthritis. J Rheumatol (2005) 0.88
Optical coherence tomography: a new tool to assess nail disease in psoriasis? Dermatology (2011) 0.88
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol (2008) 0.87
Regionalised centre of pressure analysis in patients with rheumatoid arthritis. Clin Biomech (Bristol, Avon) (2006) 0.87